norethindrone has been researched along with Hypergonadotropic Hypogonadism in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Russo, P; Trimarchi, CP | 1 |
| Anderson, RA; Kumar, N; Sattar, N; Sundaram, K; Wallace, AM | 1 |
| Alberti, I; Carrara, DN; Grenier, A; Kraus, H | 1 |
| Adnoral, SA; Bunatian, AF; Ermolenko, VM; Gitel', EP; Kukhtevich, AV; Kuznetsova, AI; Smirnova, GA | 1 |
| Knie, U; Lemmnitz, G; Nieschlag, E; Rolf, C | 1 |
| Carasso, A; Schwarz, HP; Zimmermann, A; Zuppinger, K | 1 |
| Hammerstein, J; Schwartz, U | 1 |
1 review(s) available for norethindrone and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery.
Topics: Administration, Cutaneous; Alprazolam; Animals; Anti-Anxiety Agents; Drug Delivery Systems; Estradiol; Female; Gels; Humans; Hypogonadism; Male; Mandelic Acids; Norethindrone; Parasympatholytics; Progesterone Congeners; Testosterone; Urinary Bladder, Neurogenic | 2005 |
2 trial(s) available for norethindrone and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.
Topics: Adult; Biomarkers; Body Composition; Body Weight; Bone Density; Bone Remodeling; Drug Administration Schedule; Drug Implants; Erythropoiesis; Humans; Hypogonadism; Lipoproteins; Male; Norethindrone; Organ Size; Prostate; Prostate-Specific Antigen; Sexual Behavior; Testosterone; Tissue Distribution; Ultrasonography | 2003 |
Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Gels; Hormone Antagonists; Humans; Hypogonadism; Male; Norethindrone; Risk; Skin Absorption; Testosterone; Time Factors | 2002 |
4 other study(ies) available for norethindrone and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
Cyclic estrogen-progestin hormone therapy as a new therapeutic approach in the treatment of functional alterations of the hypothalamus-pituitary-ovary axis: case reports.
Topics: Adenoma; Adult; Amenorrhea; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Feedback; Female; Humans; Hypogonadism; Hypothalamus; Norethindrone; Norethindrone Acetate; Ovary; Pituitary Gland; Pituitary Neoplasms; Polycystic Ovary Syndrome | 2002 |
[Nephropathy-related disorders of physical and sexual development in girls: experience with successful stimulation by zinc, parlodel and norcolut].
Topics: Adolescent; Bromocriptine; Combined Modality Therapy; Female; Growth Disorders; Humans; Hypogonadism; Kidney Failure, Chronic; Kidney Transplantation; Norethindrone; Renal Dialysis; Stimulation, Chemical; Zinc | 1993 |
Feminization in a galactosemic girl in the presence of hypergonadotropic hypogonadism.
Topics: Adult; Amenorrhea; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Galactosemias; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Luteinizing Hormone; Norethindrone; Ovary | 1986 |
The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity.
Topics: Adolescent; Adult; Binding Sites; Carbon Radioisotopes; Chromatography, Gel; Contraceptives, Oral; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Hypogonadism; Megestrol; Mestranol; Norethindrone; Norethynodrel; Norgestrel; Stimulation, Chemical; Time Factors; Transcortin | 1974 |